Jul 26, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.22 to $4.31.
The split itself did not change the total investment value.
Insight Molecular Diagnostics Inc. (LSE:0KCC) operates in the Biotechnology industry.
Insight Molecular Diagnostics Inc. company overviewInsight Molecular Diagnostics Inc.'s most recent stock split was on July 26, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Insight Molecular Diagnostics Inc. has split its stock once. This history records one reverse split, on July 26, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Insight Molecular Diagnostics Inc.'s 1-for-20 reverse split on July 26, 2023, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Insight Molecular Diagnostics Inc. has not announced a new split in our records. Its most recent split was on July 26, 2023, 3 years ago. Companies announce splits in advance, and any new LSE:0KCC split will appear on this page.